235 related articles for article (PubMed ID: 7859770)
21. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC
J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135
[TBL] [Abstract][Full Text] [Related]
22. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Wangberg B; Forssell-Aronsson E; Tisell LE; Nilsson O; Fjalling M; Ahlman H
Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378
[TBL] [Abstract][Full Text] [Related]
24. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
Seifert JK; Görges R; Bockisch A; Junginger T
Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
Haldemann AR; Rösler H; Barth A; Waser B; Geiger L; Godoy N; Markwalder RV; Seiler RW; Sulzer M; Reubi JC
J Nucl Med; 1995 Mar; 36(3):403-10. PubMed ID: 7884502
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor imaging in intracranial tumours.
Schmidt M; Scheidhauer K; Luyken C; Voth E; Hildebrandt G; Klug N; Schicha H
Eur J Nucl Med; 1998 Jul; 25(7):675-86. PubMed ID: 9662588
[TBL] [Abstract][Full Text] [Related]
27. True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5.
Schulz S; Helmholz T; Schmitt J; Franke K; Otto HJ; Weise W
Breast Cancer Res Treat; 2002 Apr; 72(3):221-6. PubMed ID: 12058963
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia type 1: scintigraphic and magnetic resonance demonstration.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Jan; 24(1):73-4. PubMed ID: 9890506
[No Abstract] [Full Text] [Related]
29. [Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma].
Höring E; Räth U; Rücker S; von Gaisberg U; Meincke J; Walendzik J; Dörr U; Bihl H
Dtsch Med Wochenschr; 1994 Mar; 119(11):367-74. PubMed ID: 8131715
[TBL] [Abstract][Full Text] [Related]
30. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
[TBL] [Abstract][Full Text] [Related]
31. A report of a gastrinoma localized preoperatively by endoscopic ultrasound only and a review of the approach to imaging in Zollinger-Ellison syndrome.
Bloomfeld R; Bornstein J; Jowell P
Dig Dis; 1999; 17(5-6):316-8. PubMed ID: 10838489
[TBL] [Abstract][Full Text] [Related]
32. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic and therapeutic strategy of Zollinger-Ellison syndrome. Groupe de Recherches et d'Etudes du Syndrome de Zollinger-Ellison (GRESZE)].
Bonnaud G; Cadiot G; Mignon M
Ann Chir; 1994; 48(6):535-46. PubMed ID: 7847702
[TBL] [Abstract][Full Text] [Related]
34. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
Hammond PJ; Arka A; Peters AM; Bloom SR; Gilbey SG
Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
[TBL] [Abstract][Full Text] [Related]
35. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
Frilling A; Malago M; Martin H; Broelsch CE
Surgery; 1998 Dec; 124(6):1000-4. PubMed ID: 9854575
[TBL] [Abstract][Full Text] [Related]
36. [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.
Janson ET; Westlin JE; Eriksson B; Ahlström H; Nilsson S; Oberg K
Eur J Endocrinol; 1994 Dec; 131(6):577-81. PubMed ID: 7804439
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin receptor localization of pancreatic endocrine tumors.
Corleto VD; Scopinaro F; Angeletti S; Materia A; Basso N; Polettini E; Annibale B; Schillaci O; D'Ambra G; Marignani M; Gualdi G; Bordi C; Passaro EJ; Delle Fave G
World J Surg; 1996 Feb; 20(2):241-4. PubMed ID: 8661825
[TBL] [Abstract][Full Text] [Related]
38. [Scintigraphy with 111In-octreotide in a case of primary hepatic gastrinoma].
Bello Arques P; Hervás Benito I; Mateo Navarro A
Rev Esp Med Nucl; 2001 Aug; 20(5):381-5. PubMed ID: 11470073
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease.
Krassas GE; Dumas A; Pontikides N; Kaltsas T
Clin Endocrinol (Oxf); 1995 Jun; 42(6):571-80. PubMed ID: 7634496
[TBL] [Abstract][Full Text] [Related]
40. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
Nilsson S; Reubi JC; Kalkner KM; Laissue JA; Horisberger U; Olerud C; Westlin JE
Cancer Res; 1995 Dec; 55(23 Suppl):5805s-5810s. PubMed ID: 7493350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
